1. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep. 2011.
2. Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, et al. Increases in heroin overdose deaths - 28 States, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014.
3. Hedegaard H, Chen L-H, Warner M. Drug-poisoning Deaths Involving Heroin: United States, 2000–2013 Key findings Data from the National Vital Statistics System (Mortality). NCHS Data Brief. 2015.
4. Gladden RM, Martinez P, Seth P. Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid–Involved Overdose Deaths — 27 States, 2013–2014. MMWR Morb Mortal Wkly Rep. 2016. doi:10.15585/mmwr.mm6533a2
5. O’Donnell JK, Gladden RM, Seth P. Trends in Deaths Involving Heroin and Synthetic Opioids
Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017. doi:10.15585/mmwr.mm6634a2
6. O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016, Morbidity and Mortality Weekly Report (MMWR). In: Centers for Disease Control and Prevention MMWR Office. 2017.
7. Liu S, Gladden Ma, Vivolo-Kantor AM, Seth P. Trends in Suspected Opioid Overdoses from Emergency Departments in 11 States and DC. Online J Public Health Inform. 2019. doi:10.5210/ojphi.v11i1.9935
8. DEA. 2019 National Drug Threat Assessment. Drug Enforcement Administration. 2019.
9. UNODC 2021, Crime UNO of D and. World Drug Report 2021 - Drug Market Trends : Cannabis Opioids. In: World Drug Report 2021. 2021.
10. Onohuean H, Oosthuizen F. Multinational appraisal of the epidemiological distribution of opioid fatalities: a systematic review and meta-analysis. Front Psychiatry. 2023;14: 1290461. doi:10.3389/FPSYT.2023.1290461
11. CDC. U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020 - But Are Still Up 15%. 2022 [cited 8 Jul 2022]. Available: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm
12. Public Health Agency of Canada. Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and Stimulant-related Harms in Canada. Ottawa. 2022 [cited 8 Jul 2022]. Available:
https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
13. Stigliano G, Miuli A, Lalli A, Alessi MC, Sociali A, Esposito F, et al. An Italian survey of opioids misuse: Epidemiological and psychopathological aspects. Emerg Trends Drugs, Addict Heal. 2021. oi:10.1016/j.etdah.2021.100029
14. Jobski K, Dörks
M, Bantel C, Hoffmann F. Regional differences in opioid prescribing in Germany
– results of an analysis of health insurance data of 57 million adult people. J
Pain Res. 2020. doi:10.2147/JPR.S259009
15. Ikhayere JI, Babalola AI, Yelwa M. Effect of Substance Abuse on Nigeria’s Economic Performance. Int J Soc Sci Econ Rev. 2020. doi:10.36923/ijsser.v2i2.63
16. UNODC. Nations Office on Drugs and Crime (UNODC) Survey on Drug Use in Nigeria 2019. 2018; 1–63. Available:
https://www.unodc.org/documents/nigeria//Drug_Use_Survey_Nigeria_2019_BOOK.pdf
17. Danso M, Anto F. Factors Associated with Tramadol Abuse: A Cross-Sectional Study Among Commercial Drivers and Assistants in the Accra Metropolitan Area of Ghana. Drugs - Real World Outcomes. 2021. doi:10.1007/s40801-021-00247-6
18. United Nations Office on Drugs and Crime (UNODC). Analysis of drug markets: Opiates, cocaine, cannabis, synthetic drugs (World Drug Report 2018). United Nations. 2018.
19. Salm-Reifferscheidt L. Tramadol: Africa’s opioid crisis. Lancet (London, England). 2018. doi:10.1016/S0140-6736(18)31073-0
20. Drugs smuggling in Africa: The Smack Track. Econ (United Kingdom). 2015.
21. Ratliff EA, McCurdy SA, Mbwambo JKK, Lambdin BH, Voets A, Pont S, et al. An Overview of HIV Prevention Interventions for People Who Inject Drugs in Tanzania. Adv Prev Med. 2013. doi:10.1155/2013/183187
22. Tan AX, Kapiga S, Khoshnood K, Bruce RD. Epidemiology of drug use and HIV-related risk behaviors among people who inject drugs in Mwanza, Tanzania. PLoS One. 2015. doi:10.1371/journal.pone.0145578
23. Tiberio J, Laurent YI, Ndayongeje J, Msami A, Welty S, Ngonyani A, et al. Context and characteristics of illicit drug use in coastal and interior Tanzania. Int J Drug Policy. 2018. doi:10.1016/j.drugpo.2017.09.012
24. Ngarachu EW, Kiburi SK, Owiti FR, Kangethe R. The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Subst Abus Treat Prev Policy. 2022;17: 1–8. doi:10.1186/S13011-022-00437-7/TABLES/6
25. Lelei K, Muteti J, Okioma V, Njenga A. Policy Brief on National Survey on Alcohol and Drug Abuse among Secondary School Students in Kenya. VOLUME 3: JUNE 2020. 2021.
26. AbdelWahab MA, Abou el Magd SF, Grella CE, Enaba DA, Abdel Maqsoud R. An examination of motives for tramadol and heroin use in an Egyptian sample. J Addict Dis. 2018. doi:10.1080/10550887.2019.1623650
27. Metuge CE, Dzudie A, Ebasone PV, Assob JCN, Ngowe MN, Njang E, et al. Prevalence and factors associated with substance use among students in tertiary institutions in Buea, Cameroon. Pan Afr Med J. 2022. doi:10.11604/pamj.2022.41.103.29272
28. Loffredo CA, Boulos DNK, Saleh DA, Jillson IA, Garas M, Loza N, et al. Substance use by egyptian youth: Current patterns and potential avenues for prevention. Subst Use Misuse. 2015. doi:10.3109/10826084.2014.997391
29. Syvertsen JL, Agot K, Ohaga S, Bazzi AR. You can’t do this job when you are sober: Heroin use among female sex workers and the need for comprehensive drug treatment programming in Kenya. Drug Alcohol Depend. 2019.
doi:10.1016/j.drugalcdep.2018.10.019
30. Bassiony MM, Abdelghani M, Salah El-Deen GM, Hassan MS, El-Gohari H, Youssef UM. Opioid use disorders attributed to tramadol among egyptian university students. J Addict Med. 2018. doi:10.1097/ADM.0000000000000380
31. Abd-Elkader MR, Kabbash IA, El-Sallamy RM, El-Sawy H, Gad ESAH. Tramadol abuse among workers in
an industrial city in mid-Nile Delta region, Egypt. Environ Sci Pollut Res. 2020. doi:10.1007/s11356-020-08040-8
32. Needle R, Kroeger K, Belani H, Achrekar A, Parry CD, Dewing S. Sex, drugs, and HIV: Rapid assessment of HIV risk behaviors among street-based drug using sex workers in Durban, South Africa. Soc Sci Med. 2008. doi:10.1016/j.socscimed.2008.06.031
33. Kurth AE, Cherutich P, Conover R, Chhun N, Bruce RD, Lambdin BH. The Opioid Epidemic in Africa and Its Impact. Current Addiction Reports. 2018. doi:10.1007/s40429-018-0232-9
34. Saleem HT, Likindikoki S, Nonyane BAS, Haruna Nkya I, Zhang L, Mbwambo J, et al. Correlates of Non-fatal, Opioid Overdose among Women Who Use Opioids in Dar es Salaam, Tanzania. Drug Alcohol Depend. 2021. doi:10.1016/j.drugalcdep.2020.108419
35. Moonien V, Riana |, Randrianarisoa R. LUCIA BIRD | JULIA STANYARD The evolving illicit drug trade in the western Indian Ocean. 2021.
36. UNODC. TRANSNATIONAL ORGANIZED CRIME IN EASTERN AFRICA: A Threat Assessment. 2013 [cited 14 Jul 2022]. Available: www.unodc.org
37. Haysom S, Gastrow P, Shaw M. The heroin coast A political economy along the eastern African seaboard. 2018.
38. Onohuean H, Alagbonsi AI, Usman IM, Iceland Kasozi K, Alexiou A, Badr RH, et al. Annona muricata Linn and Khaya grandifoliola C.DC. Reduce Oxidative Stress In Vitro and Ameliorate Plasmodium berghei-Induced Parasitemia and Cytokines in BALB/c Mice. J Evidence-Based Integr Med. 2021. doi:10.1177/2515690X211036669
39. Onohuean H, Jr EOA, Igere BE. Meta-synthesis and science mapping analysis of HIV / HPV co-infection : a global perspective with emphasis on Africa. 2022; 1–20.
40. Onohuean H, Okoh AI, Nwodo UU. Epidemiologic potentials and correlational analysis of Vibrio species and virulence toxins from water sources in greater Bushenyi districts, Uganda. Sci Rep. 2021; 17. doi:doi.org/10.1038/s41598-021-01375-3
41. Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015. doi:10.1371/journal.pntd.0003832
42. World Health Organization W. WHO Global Malaria Programme World Malaria Report 2015. World Health. 2015. doi:ISBN 978 92 4 1564403
43. UNODC. Executive summary — Conclusions and policy implications. 2018. doi:10.18356/a1062695-en
44. UNODC. World Drugs Report 2019. Competitiveness and Knowledge. 2018.
45. Wilson M, Brumwell A, Stowe MJ, Shelly S, Scheibe A. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs. Harm Reduct J. 2022. doi:10.1186/s12954-021-00561-w
46. Lekoane BKM, Mashamba-Thompson TP, Ginindza TG. Mapping evidence on the distribution of human papillomavirus-related cancers in sub-Saharan Africa: Scoping review protocol. Syst Rev. 2017;6: 1–5. doi:10.1186/s13643-017-0623-3
47. Onohuean H, Aigbogun EO, Igere BE. Meta-synthesis and science mapping analysis of HIV/HPV co-infection: a global perspective with emphasis on Africa. Global Health. 2022;18: 1–20. doi:10.1186/s12992-022-00812-w
48. UN Joint Programme on HIV/AIDS (UNAIDS). 90-90-90 An ambitious treatment target to help end the AIDS epidemicto help end the AIDS epidemic. United Nations. 2014.
49. WHO. An ambitious treatment target to help end the AIDS epidemic. Unaids. 2016.
50. Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE. Defining control of HIV epidemics. The Lancet HIV. 2018. doi:10.1016/S2352-3018(18)30178-4
51. Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015. doi:10.1097/XEB.0000000000000050
52. Topmiller M, Mallow PJ, Vissman AT, Grandmont J. Identifying Priority Areas for Increasing the Supply of Medication-Assisted Treatments for Opioid Use Disorder: A Geospatial Approach. J Heal Econ Outcomes Res. 2018. doi:10.36469/9787
53. High PM, Marks K, Robbins V, Winograd R, Manocchio T, Clarke T, et al. State targeted response to the opioid Crisis grants (opioid STR) program: Preliminary findings from two case studies and the national cross-site evaluation. J Subst Abuse Treat. 2020. doi:10.1016/j.jsat.2019.06.008
54. Milne EP. Family Recovery Solutions for Opioid Use Disorder Patients: A Historical Cohort Study. ProQuest Dissertations and Theses. 2018.
55. The Joanna Briggs Institute. Joanna Briggs Institute Reviewer’s Manual. In: The Joanna Briggs Institute. 2014.
56. Montilla AM, Gómez-García F, Gómez-Arias PJ, Gay-Mimbrera J, Hernández-Parada J, Isla-Tejera B, et al. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata. Dermatology and Therapy. 2019. doi:10.1007/s13555-019-00329-y
57. Aromataris E MZ (Editors). About this Manual - JBI Reviewer’s Manual. In: oanna Briggs Institute Reviewer’s Manual. 2017.
58. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine. 2018. doi:10.7326/M18-0850